Osimertinib vs Polatuzumab Vedotin

## Osimertinib vs Polatuzumab Vedotin: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Polatuzumab Vedotin**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Polatuzumab Vedotin — N/A.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Polatuzumab Vedotin — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Polatuzumab Vedotin — N/A.

**Type**: Osimertinib — Small molecule; Polatuzumab Vedotin — Antibody drug conjugate.